Skip to content

Gilead Global Public Health Awards 2026: Funding for Early Career Researchers

Share

Gilead Global Public Health Awards 2026: Funding for Early Career Researchers

Bright

Published
Share

Gilead Global Public Health Awards 2026: Funding for Early Career Researchers

The Gilead Global Public Health Awards 2026 offer a significant opportunity for early career researchers and public health professionals. This program provides up to $100,000 in research funding over two years. It is specifically designed for individuals from low- and middle-income countries who are dedicated to advancing research in HIV and viral hepatitis. The awards aim to build research capacity globally by supporting emerging investigators focused on issues affecting populations at risk for or living with viral hepatitis B, C, D, and HIV.

The initiative emphasizes sustainable development goals and implementation science. This means the funding supports research that can create real-world impact within local healthcare systems and communities. By empowering junior faculty, postdoctoral researchers, and public health professionals, the Gilead Global Public Health Awards help them establish independent research careers while addressing urgent public health challenges in their home countries and regions.

About the Gilead Global Public Health Awards

The Global Public Health Awards are dedicated to supporting independent early career investigators from eligible low- and middle-income countries worldwide. The core mission is to foster country-driven and locally relevant research that leads to better health outcomes for people affected by HIV and viral hepatitis. The program recognizes the importance of developing local research leadership. It supports scientists who have a deep understanding of the healthcare realities, policy environments, and public health priorities within their own communities.

Subscribe for updates

Get new posts, insights, and occasional updates delivered to your inbox.

We respect your privacy.

Researchers are encouraged to propose innovative and practical projects. These projects should contribute to areas like implementation science, prevention strategies, healthcare access, public health systems, or community-centered interventions related to HIV and viral hepatitis. The awards also welcome multidisciplinary approaches. This means researchers from fields such as economics, engineering, anthropology, and psychology can apply, as long as their work directly supports HIV or viral hepatitis public health priorities.

Grant Value and Number of Awards

The 2026 Global Public Health Awards will present four research awards. Each award will provide funding of up to $100,000. This funding is intended to support a research project period of two years. The goal of this financial support is to help early career researchers establish themselves as independent investigators. It also aims to help them generate evidence that can lead to future research initiatives, publications, conference presentations, and policy development.

Application Deadline

The deadline for submitting applications for the Gilead Global Public Health Awards 2026 is August 28, 2026, at 11:59 PM CEST. It is highly recommended that applicants start preparing their proposals well in advance. This is because supporting documents, mentorship arrangements, institutional approvals, and budget details often require significant time to gather and finalize.

Eligibility Requirements

To be considered for the Global Public Health Awards 2026, applicants must meet several key criteria.

Academic Qualifications

Applicants must hold a terminal degree at the time of application. This includes degrees such as MD, MBChB, MBBS, PhD, or an equivalent qualification.

Early Career Status

Applicants must be within 10 years of completing their terminal degree. However, the program allows for exceptions. These can be made for career interruptions such as parental leave, family bereavement, or other approved reasons.

Employment and Institutional Affiliation

Applicants must currently be employed by an academic research institution, hospital, ministry of health, or a recognized public health organization. They should also be on a path toward a scientific research appointment, faculty position, or an equivalent research leadership role.

Research Mentor Requirement

A crucial requirement is having an in-country research mentor. This mentor should have extensive experience in fields related to HIV, viral hepatitis, or implementation science. Relevant disciplines include public health, economics, engineering, anthropology, psychology, behavioral sciences, and health systems research.

Research Commitment

Awardees must be able to dedicate approximately 50% of their professional time to research activities over the two-year award period. This means balancing research responsibilities with limited administrative, clinical, or teaching duties.

Research Focus

Applicants must show a strong interest in public health research focused on HIV and/or viral hepatitis. They must also demonstrate the ability to complete their proposed research within the two-year award timeframe. The potential to generate valuable evidence through manuscripts, conference presentations, research abstracts, and future grant applications is also important.

Eligible Regions and Countries

The awards are open to applicants residing in eligible countries or regions within Africa, the Commonwealth of Independent States, South Asia, and Southeast Asia. Applicants must also be citizens or permanent residents of the country where the research will take place. Alternatively, they can hold a valid temporary study or non-immigrant visa that permits them to conduct research for the entire two-year award period. Those on temporary visas must also show they are eligible for visa renewal or extension if needed.

Research Areas Supported

The program supports research across a range of critical areas. These include HIV prevention and care, viral hepatitis B, C, and D, and public health implementation science. It also supports research related to sustainable development goals in healthcare, community health systems, prevention strategies, access to healthcare services, and health equity initiatives. The focus is on practical, country-driven solutions that can improve public health outcomes and strengthen healthcare delivery systems.

Research Activities That Are NOT Eligible

Certain types of research projects are not eligible for funding under these awards.

Product-Specific Research

Projects that focus directly on investigating Gilead products, comparing pharmaceutical products, or conducting product-specific safety or efficacy studies are not allowed. Cost-effectiveness studies for specific drugs also fall into this category. However, broad discussions of generic HIV prevention or treatment products within public health research contexts are acceptable.

Clinical Intervention Studies

The program does not fund interventional clinical trials, pharmaceutical drug administration studies, or clinical studies focused on the safety or efficacy of competitor drugs.

Co-Principal Investigator Applications

Applications must be submitted by a single lead investigator. Co-principal investigators are not eligible to apply.

Duplicate Funding

Projects cannot overlap with existing grants, pending funding sources, or institutional or governmental funding that covers the same activities. Applicants must clearly show that there is no direct duplication of financial support.

Why This Opportunity Matters

The Global Public Health Awards represent a significant investment in strengthening research leadership in low- and middle-income countries. This initiative helps emerging researchers build independent careers, generate locally relevant public health evidence, and enhance their implementation science capacity. It also contributes to sustainable healthcare improvements and expands opportunities for publications and conference presentations, ultimately boosting future grant competitiveness. For many early career investigators, this funding can be a crucial step toward becoming recognized public health researchers both nationally and internationally.

Tips for Preparing a Strong Application

To increase the chances of a successful application, researchers should consider the following tips.

Develop a Country-Relevant Research Question

Focus on research questions that address challenges that are locally important and public health driven. Ensure the question is directly relevant to HIV or viral hepatitis priorities in your country.

Demonstrate Implementation Potential

Strong proposals often highlight real-world applicability, potential community impact, and policy relevance. They should also show how interventions could be scaled up.

Highlight Mentorship Support

Clearly explain your mentor’s expertise and the institutional support available. Detail the research environment and the career development opportunities the mentorship provides.

Build a Realistic Timeline

Ensure the proposed project can reasonably be completed within the two-year award period. Include clear, measurable outputs and milestones.

Ensure Budget Clarity

Provide detailed financial information for the project. Avoid any overlap with existing grants or other funding streams.

Frequently Asked Questions

What is the main goal of the Gilead Global Public Health Awards?

The main goal is to support early career researchers from low- and middle-income countries to build research capacity and address public health challenges related to HIV and viral hepatitis.

How much funding is available through the awards?

Each of the four awards provides up to $100,000 in research funding, intended to support a project over a two-year period.

Who is eligible to apply for the awards?

Eligible applicants must hold a terminal degree, be within 10 years of completing it, be employed by a research institution or similar organization, have an in-country mentor, and commit 50% of their time to research.

What types of research are not supported by these awards?

The awards do not fund research focused on specific Gilead products, clinical intervention trials, or studies that duplicate existing funding.

Posted in: GENERAL

Related Posts

Conversation

0 Comments

Leave a comment

Your email address will not be published. Required fields are marked *